Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 21, 2001

View Archived Issues

Xenova, Cantab Merging Via All-Stock Deal Valued At £124

Anti-Inflammatory Drugs Could Help Dementia, Study Reports

Pharming Completes Study, Enters Deal With AM-Pharma

EU Parliament, Ministers Agree To New Rules Covering Biotech

Teva Establishing Biotech Fund As Growth Continues In Israel

Other News To Note

Cyclacel Moves Oral CDK Inhibitor Into Human Trials

Tibotec Reports Potent Activity In Two Classes Of HIV Drugs

Sweden Plans To Use Presidency To Improve Biotechnology Climate

DrugAbuse Reports Positive Phase II Results Of Naltrel

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...